Literature DB >> 12811468

Response to van Saene et al.'s comment on "Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients".

Thierry Calandra, Oscar Marchetti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12811468     DOI： 10.1007/s00134-003-1842-8

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  10 in total

Review 1.  Prophylactic antifungal therapy in the intensive care unit.

Authors:  J H Rex; J D Sobel
Journal:  Clin Infect Dis       Date:  2001-03-26       Impact factor: 9.079

2.  Comment on "Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients," by Garbino et al.

Authors:  H K F Van Saene; L Silvestri; A Petros; M Viviani; M A de la Cal; D F Zandstra
Journal:  Intensive Care Med       Date:  2003-05-16       Impact factor: 17.440

3.  Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients.

Authors:  R K Pelz; C W Hendrix; S M Swoboda; M Diener-West; W G Merz; J Hammond; P A Lipsett
Journal:  Ann Surg       Date:  2001-04       Impact factor: 12.969

4.  Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients.

Authors:  P Eggimann; P Francioli; J Bille; R Schneider; M M Wu; G Chapuis; R Chiolero; A Pannatier; J Schilling; S Geroulanos; M P Glauser; T Calandra
Journal:  Crit Care Med       Date:  1999-06       Impact factor: 7.598

5.  Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation.

Authors:  C Lumbreras; V Cuervas-Mons; P Jara; A del Palacio; V S Turrión; C Barrios; E Moreno; A R Noriega; C V Paya
Journal:  J Infect Dis       Date:  1996-09       Impact factor: 5.226

Review 6.  Practical modalities for prevention of fungal infections in cancer patients.

Authors:  B E De Pauw
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-01       Impact factor: 3.267

7.  Routine prophylactic antifungal agents (clotrimazole, ketoconazole, and nystatin) in nontransplant/nonburned critically ill surgical and trauma patients.

Authors:  J A Savino; N Agarwal; P Wry; A Policastro; T Cerabona; L Austria
Journal:  J Trauma       Date:  1994-01

8.  Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group.

Authors:  J N Philpott-Howard; J J Wade; G J Mufti; K W Brammer; G Ehninger
Journal:  J Antimicrob Chemother       Date:  1993-06       Impact factor: 5.790

9.  Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination.

Authors:  Jorge Garbino; Daniel P Lew; Jacques-A Romand; Stéphane Hugonnet; Raymond Auckenthaler; Didier Pittet
Journal:  Intensive Care Med       Date:  2002-11-01       Impact factor: 17.440

10.  Ketoconazole prevents Candida sepsis in critically ill surgical patients.

Authors:  G J Slotman; K W Burchard
Journal:  Arch Surg       Date:  1987-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.